Publications
Identifying risk of future asthma attacks using UK medical record data: a Respiratory Effectiveness Group initiative
21 December 2016
Journal of Allergy and Clinical Immunology: In Practice
John D Blakey, David Price, Emilio Pizzichini, Todor A Popov, Borislav D Dimitrov, Dirkje S. Postma, Lynn K. Josephs, Alan Kaplan, Alberto Papi, Marjan Kerkhof, Elizabeth V Hillyer, Alison Chisholm, Mike Thomas
Inappropriate asthma therapy — a tale of two countries: a parallel population-based cohort study
12 October 2016
NPJ Primary Care Respiratory Medicine
Manon Belhassen, Anjan Nibber, Eric Van Ganse, Dermot Ryan, Carole Langlois, Francis Appiagyei, Derek Skinner, Laurent Laforest, Joan B Soriano, David Price
Asthma-related outcomes in patients initiating extrafine ciclesonide or fine-particle inhaled corticosteroids
10 October 2016
Allergy, Asthma & Immunology Research
Dirkje S. Postma, Richard Dekhuijzen, Thys van der Molen, Richard J. Martin, Wim van Aalderen, Nicolas Roche, Theresa W. Guilbert, Elliot Israel, Daniela van Eickels, Javaria Mona Khalid, Ron M.C. Herings, Jetty A. Overbeek, Cristiana Miglio, Victoria Thomas, Catherine Hutton, Elizabeth V. Hillyer, David Price
Metabolic effects associated with ICS in patients with COPD and comorbid type 2 diabetes: a historical matched cohort study
21 September 2016
PLOS ONE
David Price, Richard Russell, Rafael Mares, Anne Burden, Derek Skinner, Helga Mikkelsen, Cherlyn Ding, Richard Brice, Niels H. Chavannes, Janwillem W. H. Kocks, Jeffrey W. Stephens, John Haughney
Incidence of oral thrush in patients with COPD prescribed inhaled corticosteroids: effect of drug, dose, and device
21 September 2016
Respiratory Medicine
P.N. Richard Dekhuijzen, Maria Batsiou, Leif Bjermer, Sinthia Bosnic-Anticevich, Henry Chrystyn, Alberto Papi, Roberto Rodríguez-Roisin, Monica Fletcher, Lucy Wood, Alessandra Cifra, Joan B. Soriano, David Price
Long-acting β-agonist in combination or separate inhaler as step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids
12 July 2016
Journal of Allergy and Clinical Immunology: In Practice
Steve Turner, Kathryn Richardson, Clare Murray, Mike Thomas, Elizabeth V. Hillyer, Anne Burden, David Price, Respiratory Effectiveness Group
UK prescribing practices as proxy markers of unmet need in allergic rhinitis: a retrospective observational study
22 June 2016
NPJ Primary Care Respiratory Medicine
David Price, Glenis Scadding, Claus Bachert, Hesham Saleh, Shuaib Nasser, Victoria Carter, Julie von Ziegenweidt, Alice MS Durieux, Dermot Ryan
Excess costs associated with possible misdiagnosis of Alzheimer’s disease among patients with vascular dementia in a UK CPRD population
21 June 2016
Journal of Alzheimer’s Disease
Michael Happich, Noam Y. Kirson, Urvi Desai, Sarah King, Howard G. Birnbaum, Catherine Reed, Mark Belger, Alan Lenox-Smith, David Price
Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands
16 May 2016
BMC Pulmonary Medicine
Thys van der Molen, Dirkje S. Postma, Richard J. Martin, Ron M.C. Herings, Jetty A. Overbeek, Victoria Thomas, Cristiana Miglio, Richard Dekhuijzen, Nicolas Roche, Theresa Guilbert, Elliot Israel, Wim van Aalderen, Elizabeth V. Hillyer, Simon van Rysewyk, David Price
Add-on LABA in a separate inhaler as asthma step-up therapy versus increased dose of ICS or ICS/LABA combination inhaler
31 March 2016
ERJ Open Research
David Price, Gene Colice, Elliot Israel, Nicolas Roche, Dirkje S. Postma, Theresa W. Guilbert, Willem M.C. van Aalderen, Jonathan Grigg, Elizabeth V. Hillyer, Vicky Thomas, Richard J. Martin
Cost-effectiveness of asthma step-up therapy as an increased dose of extrafine-particle inhaled corticosteroid or add-on long-acting beta2-agonist
20 March 2016
Pulmonary Therapy
Nicolas Roche, Gene Colice, Elliot Israel, Richard J. Martin, Paul M. Dorinsky, Dirkje S. Postma, Theresa W. Guilbert, Jonathan Grigg, Willem M. C. van Aalderen, Francesca Barion, Elizabeth V. Hillyer, Victoria Thomas, Anne Burden, R. Brett McQueen, David Price
Reply [Inhaled corticosteroids for asthma therapy in young children: does aerosol particle size matter?
1 March 2016
Journal of Allergy and Clinical Immunology: In Practice
Willem M. C. van Aalderen, Jonathan Grigg, Theresa W. Guilbert, Nicolas Roche, Gene Colice, Dirkje S. Postma, Elizabeth V. Hillyer, David Price
Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: in UK primary care: a real-world, retrospective, observational
25 February 2016
NPJ Primary Care Respiratory Medicine
Kevin Gruffydd-Jones, Guy Brusselle, Rupert Jones, Marc Miravitlles, Michael Baldwin, Rebecca Stewart, Anna Rigazio, Emily Davis, Dorothy L Keininger, David Price
Erratum: Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: a real-world study
24 February 2016
NPJ Primary Care Respiratory Medicine
Kevin Gruffydd-Jones, Guy Brusselle, Rupert Jones, Marc Miravitlles, Michael Baldwin, Rebecca Stewart, Anna Rigazio, Emily Davis, Dorothy L Keininger, David Price
Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting
25 January 2016
Journal of Asthma
Janine A.M. Westerik, Victoria Carter, Henry Chrystyn, Anne Burden, Samantha L. Thompson, Dermot Ryan, Kevin Gruffydd-Jones, John Haughney, Nicolas Roche, Federico Lavorini, Alberto Papi, Antonio Infantino, Miguel Román-Rodríguez, Sinthia Bosnic-Anticevich, Karin Lisspers, Björn Ställberg, Svein Høegh Henrichsen, Thys van der Molen, Catherine Hutton, David Price